Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 49 Records) |
Query Trace: Body Weight and CYP2C9[original query] |
---|
Multivariate analysis of the relation between diet and warfarin dose. European journal of clinical pharmacology 2012 Mar 68 (3): 321-8. Rasmussen Morten Arendt, Skov Jane, Bladbjerg Else-Marie, Sidelmann Johannes J, Vamosi Marianne, Jespersen Jørg |
A pharmacokinetic-pharmacodynamic model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy. Clinical pharmacokinetics 2012 Jan 51 (1): 41-53. Verstuyft Céline, Delavenne Xavier, Rousseau Alexandra, Robert Annie, Tod Michel, Diquet Bertrand, Lebot Martine, Jaillon Patrice, Becquemont Laure |
Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation. Clinical therapeutics 2011 Oct 33 (10): 1371-80. Cho Hyun-Jung, On Young-Keun, Bang Oh Young, Kim Jong-Won, Huh Wooseong, Ko Jae-Wook, Kim June Soo, Lee Soo-Yo |
White blood cells contribute to patient-specific warfarin dose for Han Chinese. Chinese medical journal 2012 Jun 125 (11): 1960-3. Zhu Jin, Zheng Wen-Jie, Zhang Wei-Juan, Wang He-Yao, Wang Ch |
The combined effects of clinical factors and CYP2C9 and VKORC1 gene polymorphisms on initiating warfarin treatment in patients after cardiac valve surgery. The Journal of heart valve disease 2012 Sep 21 (5): 5. Tatar?nas V, Lesauskaite V, Veikutiene A, Grybauskas P, Jakuska P, Benetis R |
Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT. Bone marrow transplantation 2012 Sep 47 (9): 1178-85. Balasubramanian P, Desire S, Panetta J C, Lakshmi K M, Mathews V, George B, Viswabandya A, Chandy M, Krishnamoorthy R, Srivastava |
Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population. European journal of clinical pharmacology 2014 Jan 70 (1): 47-56. Krishna Kumar Dhakchinamoorthi, Shewade Deepak Gopal, Loriot Marie-Anne, Beaune Philippe, Balachander Jayaraman, Sai Chandran B V, Adithan Chandrasekar |
Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic model. Clinical pharmacokinetics 2013 May 52 (5): 359-71. Abduljalil Khaled, Lazar Simone, Natanzon Michael, Wu Weidong, Zadoyan Gregor, Steffens Benedict, Kohl Victoria, Mörike Klaus, Tomalik-Scharte Dorota, Stingl Julia, Schwab Matthias, Harenberg Job, Gleiter Christoph, Fuhr U |
Prediction of warfarin maintenance dose in Han Chinese patients using a mechanistic model based on genetic and non-genetic factors. Clinical pharmacokinetics 2013 Jul 52 (7): 567-81. Lu Yuan, Yang Jinbo, Zhang Haiyan, Yang J |
Individualized phenytoin therapy for Japanese pediatric patients with epilepsy based on CYP2C9 and CYP2C19 genotypes. Therapeutic drug monitoring 2015 Apr 37 (2): 229-35. Yamamoto Yoshiaki, Takahashi Yukitoshi, Imai Katsumi, Miyakawa Kou, Ikeda Hiroko, Ueda Yuki, Yamaguchi Tokito, Nasu Hirosato, Ohtani Hideyuki, Shigematsu Hideo, Kagawa Yoshiyuki, Inoue Yus |
CYP2C9, VKORC1, CYP4F2, ABCB1 and F5 variants: influence on quality of long-term anticoagulation. Pharmacological reports : PR 2014 Apr 66 (2): 243-9. Nahar Risha, Saxena Renu, Deb Roumi, Parakh Rajiv, Shad Sujay, Sethi Prahlad K, Takkar Parul, Verma Ishwar |
[Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2014 Jan 35 (1): 13-7. Zhuang Wenfang, Wu Depei, Wang Zhaoy |
Effect of CYP2C9, CYP4F2 and VKORC1 genetic polymorphisms on pharmacokinetics and pharmacodynamics of mean daily maintenance dose of warfarin in Chinese patients. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015 Mar 26 (2): 167-74. Zhuang Wenfang, Wen Wei, Xuan Binbin, Chen Yanhong, Cao Yanan, Sun Zhixin, Ma J |
Differences in CYP2C9 Genotype and Enzyme Activity Between Swedes and Koreans of Relevance for Personalized Medicine: Role of Ethnicity, Genotype, Smoking, Age, and Sex. Omics : a journal of integrative biology 2015 May . Hatta Fazleen H M, Lundblad Mia, Ramsjo Margareta, Kang Ju-Hee, Roh Hyung-Keun, Bertilsson Leif, Eliasson Erik, Aklillu Ele |
CYP2C19*17 affects R-warfarin plasma clearance and warfarin INR/dose ratio in patients on stable warfarin maintenance therapy. European journal of clinical pharmacology 2015 Apr 71 (4): 433-9. Chang Ming, Söderberg Mao Mao, Scordo Maria Gabriella, Tybring Gunnel, Dahl Marja-Lii |
Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms. Pharmacogenomics 2015 16 (3): 217-25. Nagai Rui, Ohara Minami, Cavallari Larisa H, Drozda Katarzyna, Patel Shitalben R, Nutescu Edith A, Perera Minoli A, Hernandez Wenndy, Kaneko Naoko, Hibiya Manabu, Takahashi Haru |
Warfarin dosage response related pharmacogenetics in Chinese population. PloS one 2015 10 (1): e0116463. Li Siyue, Zou Yuangao, Wang Xia, Huang Xunbei, Sun Yong, Wang Yuqing, Dong Li, Jiang Ho |
Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine. Clinical pharmacokinetics 2017 05 56 (5): 525-536. Green Bruce, Crauwels Herta, Kakuda Thomas N, Vanveggel Simon, Brochot An |
Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia. European journal of clinical pharmacology 2016 Aug . Bouazza Naïm, Djerada Zoubir, Gozalo Claire, Busiah Kanetee, Beltrand Jacques, Berdugo Marianne, Urien Saik, Treluyer Jean-Marc, Polak Mich |
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms. The pharmacogenomics journal 2016 Aug . Kubo K, Ohara M, Tachikawa M, Cavallari L H, Lee M T M, Wen M S, Scordo M G, Nutescu E A, Perera M A, Miyajima A, Kaneko N, Pengo V, Padrini R, Chen Y T, Takahashi |
[Population pharmacokinetic/pharmacodynamic modeling of warfarin by nonlinear mixed effects model]. Yao xue xue bao = Acta pharmaceutica Sinica 2015 Oct 50 (10): 1280-4. Lin Rong-fang, Lin Wei-wei, Wang Chang-lian, Huang Pin-fang, Fang Su-j |
Association of Genetic Polymorphisms of CYP2C9 and VKORC1 with Bleeding Following Warfarin: A Case-Control Study. Current clinical pharmacology 2016 Jan . Thatte Urmi |
Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatment. Pharmacogenetics and genomics 2017 9 27 (11): 402-409. Marcath Lauren A, Deal Allison M, Van Wieren Emily, Danko William, Walko Christine M, Ibrahim Joseph G, Weck Karen E, Jones David R, Desta Zeruesenay, McLeod Howard L, Carey Lisa A, Irvin William J, Hertz Daniel |
Influence of NR3C1 and VDR polymorphisms on stable warfarin dose in patients with mechanical cardiac valves. International journal of cardiology 2017 Jun 236 393-397. Lee Kyung Eun, Chung Jee Eun, Yi Boram, Cho Yoon Jeong, Kim Hyun Jeong, Lee Gwan Yung, Kim Joo Hee, Chang Byung Chul, Gwak Hye S |
Polymorphisms of vitamin K-related genes (EPHX1 and VKORC1L1) and stable warfarin doses. Gene 2017 Oct . Chung Jee-Eun, Lee Kyung Eun, Chang Byung Chul, Gwak Hye S |
Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations. Clinical pharmacokinetics 2019 3 58 (8): 1077-1089. Ohara Minami, Suzuki Yasuhiko, Shinohara Saki, Gong Inna Y, Schmerk Crystal L, Tirona Rommel G, Schwarz Ute I, Wen Ming-Shien, Lee Ming Ta Michael, Mihara Kiyoshi, Nutescu Edith A, Perera Minoli A, Cavallari Larisa H, Kim Richard B, Takahashi Haru |
Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy. European journal of hospital pharmacy : science and practice 2020 Aug . Song Cangsang, Li Xingde, Mao Panpan, Song Wenbing, Liu Lu, Zhang Ya |
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients. Molecular diagnosis & therapy 2021 8 25 (6): 735-755. Hirata Thiago Dominguez Crespo, Dagli-Hernandez Carolina, Genvigir Fabiana Dalla Vecchia, Lauschke Volker Martin, Zhou Yitian, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Cres |
Genetic and Non-genetic Factors Contributing to the Significant Variation in the Plasma Trough Concentration-to-Dose Ratio of Valproic Acid in Children With Epilepsy. Frontiers in pediatrics 2021 2 8 599044. Xu Ze-Yue, Guo Hong-Li, Li Ling, Zhang Min, Jing Xia, Xu Ze-Jun, Qiu Jin-Chun, Lu Xiao-Peng, Ding Xuan-Sheng, Chen Feng, Xu Ji |
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study. BMC medicine 2022 7 20 (1): 261. Ricardo-Silgado Maria L, Singh Sneha, Cifuentes Lizeth, Decker Paul A, Gonzalez-Izundegui Daniel, Moyer Ann M, Hurtado Maria D, Camilleri Michael, Bielinski Suzette J, Acosta Andr |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: